These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11173732)

  • 1. Tumor escape mechanism involving Fas and Fas-L molecules in human colorectal tumors.
    Radfar S; Martin H; Tilkin-Mariame AF
    Gastroenterol Clin Biol; 2000 Dec; 24(12):1191-6. PubMed ID: 11173732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.
    Elnemr A; Ohta T; Yachie A; Kayahara M; Kitagawa H; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K
    Int J Oncol; 2001 Jan; 18(1):33-9. PubMed ID: 11115536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
    Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
    Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells.
    Zhu Q; Liu JY; Yang CM; Xu HW; Zhang AZ; Cui Y; Wang HB; Qin CY; Li YQ
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1071-7. PubMed ID: 16957513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis.
    Okada K; Komuta K; Hashimoto S; Matsuzaki S; Kanematsu T; Koji T
    Clin Cancer Res; 2000 Sep; 6(9):3560-4. PubMed ID: 10999744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-gamma sensitizes osteosarcoma cells to Fas-induced apoptosis by up-regulating Fas receptors and caspase-8.
    Inaba H; Glibetic M; Buck S; Ravindranath Y; Kaplan J
    Pediatr Blood Cancer; 2004 Dec; 43(7):729-36. PubMed ID: 15390286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral cancer cell lines can use multiple ligands, including Fas-L, TRAIL and TNF-alpha, to induce apoptosis in Jurkat T cells: possible mechanisms for immune escape by head and neck cancers.
    Kassouf N; Thornhill MH
    Oral Oncol; 2008 Jul; 44(7):672-82. PubMed ID: 17996489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The breakdown of apoptotic mechanism in the development and progression of colorectal carcinoma.
    Ogawa S; Nagao M; Kanehiro H; Hisanaga M; Ko S; Ikeda N; Nakajima Y
    Anticancer Res; 2004; 24(3a):1569-79. PubMed ID: 15274324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Fas antibody induces apoptosis in cultured human renal interstitial fibroblasts.
    Cheng L; Chen Y
    Chin Med J (Engl); 2001 Feb; 114(2):162-6. PubMed ID: 11780198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder cancer cells acquire competent mechanisms to escape Fas-mediated apoptosis and immune surveillance in the course of malignant transformation.
    Perabo FG; Kamp S; Schmidt D; Lindner H; Steiner G; Mattes RH; Wirger A; Pegelow K; Albers P; Kohn EC; von Ruecker A; Mueller SC
    Br J Cancer; 2001 May; 84(10):1330-8. PubMed ID: 11355943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein.
    Grassi F; Piacentini A; Cristino S; Toneguzzi S; Facchini A; Lisignoli G
    Arthritis Rheum; 2004 Feb; 50(2):498-506. PubMed ID: 14872492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
    J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-6 fatty acids can inhibit Fas-mediated apoptosis in a human colorectal carcinoma cell line: a potential mechanism for escape from immune surveillance.
    Meterissian S; Kontogiannea M; Murty H; Gupta A
    Int J Surg Investig; 2000; 2(4):253-7. PubMed ID: 12678526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel bystander effect involving tumor cell-derived Fas and FasL interactions following Ad.HSV-tk and Ad.mIL-12 gene therapies in experimental prostate cancer.
    Hall SJ; Canfield SE; Yan Y; Hassen W; Selleck WA; Chen SH
    Gene Ther; 2002 Apr; 9(8):511-7. PubMed ID: 11948376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of Fas-resistant to Fas-sensitive MCF-7 breast cancer cells by the synergistic interaction of interferon-gamma and all-trans retinoic acid.
    Danforth DN; Zhu Y
    Breast Cancer Res Treat; 2005 Nov; 94(1):81-91. PubMed ID: 16136269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Fas (APO-1/CD95) and Fas ligand (FasL) in human neuroblastoma.
    Gross N; Balmas K; Beretta Brognara C; Tschopp J
    Med Pediatr Oncol; 2001 Jan; 36(1):111-4. PubMed ID: 11464860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas ligand expression in esophageal carcinomas and their lymph node metastases.
    Younes M; Schwartz MR; Ertan A; Finnie D; Younes A
    Cancer; 2000 Feb; 88(3):524-8. PubMed ID: 10649242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel treatment of breast cancer cell lines modulates Fas/Fas ligand expression and induces apoptosis which can be inhibited through the CD40 receptor.
    Stumm S; Meyer A; Lindner M; Bastert G; Wallwiener D; Gückel B
    Oncology; 2004; 66(2):101-11. PubMed ID: 15138361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
    Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
    Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.